Literature DB >> 18028278

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.

Yutaka Komiya1, Keiko Katayama, Hisao Yugi, Masaaki Mizui, Harumichi Matsukura, Tetsushi Tomoguri, Yuzo Miyakawa, Ayako Tabuchi, Junko Tanaka, Hiroshi Yoshizawa.   

Abstract

BACKGROUND: In planning optimal hepatitis B virus (HBV) blood screening strategies, the minimum infectious dose and early dynamics of HBV need to be determined for defining the window period for HBV DNA as well as for hepatitis B surface antigen (HBsAg). STUDY DESIGN AND METHODS: Pairs of chimpanzees were inoculated with preacute-phase inocula containing HBV of genotype A or genotype C to determine the minimum infectious dose, and two pairs of chimps infected with the lowest infectious dose of genotypes A and C were followed for HBV markers.
RESULTS: The minimum 50 percent chimpanzee infectious dose (CID50) was estimated to be approximately 10 copies for genotype A and for genotype C. In the two chimps inoculated with the lowest infectious dose, the HBV DNA window was 55 to 76 days for genotype A and 35 to 50 days for genotype C, respectively. The HBsAg window was 69 to 97 days for genotype A and 50 to 64 days for genotype C, respectively. The doubling times of HBV DNA were 3.4 days (95% confidence interval [CI], 2.6-4.9 days) for genotype A and 1.9 days (95% CI, 1.6-2.3 days) for genotype C. When comparing the replication velocity of HBV DNA between the two genotypes, the doubling time of genotype C was significantly shorter than that of HBV genotype A (p < 0.01).
CONCLUSION: Although the CID50 of approximately 10 copies was similar for the two HBV genotypes, the doubling time and pre-HBV nucleic acid amplification technology (<100 copies/mL) window period in chimps infected with the lowest infectious dose seemed to be shorter for genotype C than for genotype A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028278     DOI: 10.1111/j.1537-2995.2007.01522.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  21 in total

1.  Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.

Authors:  Naveen K Vaidya; Ruy M Ribeiro; Christopher J Miller; Alan S Perelson
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 2.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

3.  Dynamics of hepatitis B virus serum markers in an acute hepatitis B patient in the incubation phase.

Authors:  Shota Okamoto; Kazumi Yamasaki; Atsumasa Komori; Seigo Abiru; Shinya Nagaoka; Akira Saeki; Satoru Hashimoto; Shigemune Bekki; Hiroaki Okamoto; Hiroshi Yatsuhashi
Journal:  Clin J Gastroenterol       Date:  2018-11-21

4.  Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity.

Authors:  Mira El Chaar; Tamima El Jisr; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

5.  Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.

Authors:  Yanli Qin; Xiaoli Tang; Tamako Garcia; Munira Hussain; Jiming Zhang; Anna Lok; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 6.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

7.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

8.  A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.

Authors:  Marion Vermeulen; Harry van Drimmelen; Charl Coleman; Josephine Mitchel; Ravi Reddy; Nico Lelie
Journal:  Transfusion       Date:  2014-04-21       Impact factor: 3.157

9.  Comparison of Two Test Strategies for Clarification of Reactive Results for Anti-HBc in Blood Donors.

Authors:  David Juhl; Johannes K-M Knobloch; Siegfried Görg; Holger Hennig
Journal:  Transfus Med Hemother       Date:  2015-11-04       Impact factor: 3.747

10.  High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.

Authors:  Zhong-Min Ma; Mars Stone; Mike Piatak; Becky Schweighardt; Nancy L Haigwood; David Montefiori; Jeffrey D Lifson; Michael P Busch; Christopher J Miller
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.